Formulation

Jan 02, 2018
Pharmaceutical Technology
The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
Jan 02, 2018
Pharmaceutical Technology
Abuse-deterrent opioid formulations generally fall into two categories: the first is based on a physiochemical abuse-deterrent approach and the second combines the opioid with an antagonist.
Dec 06, 2017
Equipment and Processing Report
Orbis Biosciences’ Optimµm Platform delivers microparticulate dosage forms with controlled-release and taste-masked properties in a single manufacturing step.
Dec 02, 2017
Pharmaceutical Technology
Amid business and regulatory uncertainty, bio/pharma experts reveal opinions on salary, recognition, and training.
Dec 02, 2017
Pharmaceutical Technology
Is pharma up to the task of developing knowledgeable, motivated employees?
Dec 02, 2017
Pharmaceutical Technology
Attracting and retaining qualified bio/pharma experts demands a mix of recognition, rewards, and opportunities.
Dec 02, 2017
Pharmaceutical Technology
Modified-release lipid-based formulations in softgel capsules can address physiochemical and pharmacokinetic challenges posed by drug compounds.
Dec 02, 2017
Pharmaceutical Technology
Softgel capsules are a popular dosage form among patients but they also provide a number of manufacturing benefits over liquid-filled hardgel capsules.
Nov 14, 2017
By Pharmaceutical Technology Editors
ADC Bio experts warn of impending problems in the ADC pipeline with millions wasted in development costs.
Nov 02, 2017
Pharmaceutical Technology
Taste masking increases drug acceptability and medication adherence in pediatric, geriatric, and other special patient populations.
native1_300x100
lorem ipsum